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Background: Contemporary evidence on clinical outcomes by gender following primary percutaneous coronary intervention (PPCI) for acute STEMI 
is lacking. We investigated whether gender differences modulate in-hospital and long-term mortality following PPCI for acute STEMI. 
Methods: A cohort of 908 consecutive STEMI patients [31% females, median age 61 years] presenting within 12 hours of symptom onset was 
studied for survival benefit. Multivariate logistic regression 
was used to assess relationship between gender and in-
hospital mortality and Cox regression to evaluate gender 
effect and long-term mortality. 
Results: Baseline characteristics are shown. Median 
door-to-balloon time was higher in women compared 
to men (70 min vs. 64 min; p=0.006), and only 66% of 
women were revascularized in <90 min compared to 74% 
of men; p<0.001. In-hospital cardiovascular mortality was 
significantly higher in the women (6.4%) compared to men 
(2.9 %); p=0.021, as was all-cause mortality (7.1% in 
women vs. 4.3% in men; p=0.084). At a median follow-up of 
3 years, significantly more women were dead compared to 
men (13.2% vs. 6.6%; p=0.022). Renal failure, peripheral 
artery disease, heart failure and a history of stroke were 
predictors of in-hospital mortality on multivariate analysis, 
while dyslipidemia and smoking strongly predicted long-
term mortality. 
Conclusion: Gender-based differences continue to exist 
in the contemporary era of PPCI for acute STEMI for both 
short- and long-term mortality. 
Baseline and Angiographic Characteristics of the Patient Population*
Gender
CHARACTERISTIC
Overall
n=908
Female
n=283
Male
n=625
p-Value
Demographics
Median age (IQR) 61 (53-72) 69 (57-79) 59 (52-68) <0.001
Medical
Previous MI 160 (17.6%) 50 (17.7%) 110 (17.6%) 0.980
Previous CHF 33 (3.6%) 21 (7.4%) 12 (1.9%) <0.001
Diabetes mellitus 199 (21.9%) 84 (29.7%) 115 (18.4%) <0.001
Renal failure 20 (2.2%) 10 (3.5%) 10 (1.6%) 0.066
Hypertension 500 (55.1%) 181 (64.0%) 319 (51.0%) <0.001
Cerebrovascular accident 72 (7.9%) 31 (11.0%) 41 (6.6%) 0.023
Peripheral artery disease 54 (6.0%) 21 (7.4%) 33 (5.3%) 0.207
Current tobacco use 584 (64.3%) 151 (53.4%) 433 (69.3%) <0.001
Dyslipidemia 510 (56.2%) 174 (61.5%) 336 (53.8%) 0.299
Chronic airway disease 108 (11.9%) 46 (16.3%) 62 (9.9%) 0.006
Previous PCI 221 (24.3%) 63 (22.3%) 158 (25.3%) 0.326
Previous CABG 67 (7.4%) 18 (6.4%) 49 (7.8%) 0.430
Admission EF - % (IQR) 50 (40-60) 50 (40-60) 50 (40-60) 0.966
Medications
GP IIbIIIa 775 (85.4%) 228 (80.6%) 545 (87.4%) 0.058
Direct Thrombin Inhibitors 167 (18.4%) 60 (21.3%) 107 (17.2%) 0.329
UFH-Heparin 839 (92.4%) 256 (90.6%) 581 (93.2%) 0.405
Aspirin 900 (99.1%) 281 (99.4%) 619 (98.9%) 0.982
Betablocker 799 (88.0%) 248 (87.5%) 551 (88.3%) 0.922
Clopidogrel 858 (94.5%) 270 (95.6%) 588 (94.0%) 0.582
Warfarin 23 (2.5%) 11 (3.8%) 12 (1.9%) 0.345
Statin 706 (77.8%) 225 (79.4%) 481 (77.1%) 0.634
Ticlopidine 40 (4.4%) 12 (4.4%) 28 (4.4%) 0.820
ACEI 546 (60.1%) 179 (63.3%) 367 (58.7%) 0.445
ARB 53 (5.9%) 19 (6.7%) 34 (5.6%) 0.839
Infarct-Related Artery
RCA 396 (43.6%) 132 (46.6%) 264 (42.2%) 0.215
LAD 285 (31.4%) 91 (32.2%) 194 (31.0%) 0.737
Circumflex 103 (11.3%) 28 (9.9%) 75 (12.0%) 0.354
Marginal 54 (6.0%) 13 (4.6%) 36 (5.8%) 0.246
Diagonal 19 (2.1%) 4 (1.4%) 15 (2.4%) 0.336
Others 51 (5.6%) 15 (5.3%) 36 (5.8%) 0.781
Pre TIMI Flow
0 581 (64.0%) 173 (61.1%) 408 (65.3%) 0.228
1 33 (3.6%) 13 (4.6%) 20 (3.2%) 0.299
2 158 (17.4%) 51 (18.0%) 107 (17.1%) 0.740
3 136 (15.0%) 46 (16.3%) 90 (14.4%) 0.468
Post TIMI Flow
0 18 (2.0%) 5 (1.8%) 13 (2.1%) 0.754
1 5 (0.6%) 2 (0.7%) 3 (0.5%) 0.650
2 19 (2.1%) 2 (0.7%) 17 (2.7%) 0.076
3 866 (95.4%) 274 (96.8%) 592 (94.7%) 0.163
PCI
No stents 105 (11.6%) 33 (11.7%) 72 (11.5%) 0.951
Bare metal stents 451 (49.7%) 139 (49.1%) 312 (49.9%) 0.823
Drug-eluting stents 332 (36.6%) 108 (38.2%) 224 (35.8%) 0.501
Bare and drug-eluting stents 20 (2.2%) 3 (1.1%) 17 (2.7%) 0.115
CABG 53 (5.8%) 14 (5.0%) 39 (6.2%) 0.441
*Differences in patients’ demographic and clinical characteristics were compared across gender groups with chi-square tests or Fisher’s exact tests (2-tailed).
Abbreviations: ACEI=angiotensin-converting enzyme inhibitors; ARB=angiotensin receptor blocking agents; CABG=coronary artery bypass grafting; CAD= coronary artery disease; CHF=congestive heart failure; 
EF=ejection fraction; IQR=interquartile range; LAD=left anterior descending artery; MI=myocardial infarction; PCI=percutaneous coronary intervention; RCA=right coronary artery.
